- Fee assured
- Verified this account
Dr Sharp qualified from Edinburgh Medical School in 1998 and was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011.
He conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training. He completed the prestigious Milan-Imperial Interventional Cardiology Fellowship programme, having spent a year in San Raffaele and Columbus hospitals, Milan, Italy, under the tutelage of Professor Antonio Colombo. He also spent three years training in interventional cardiology at St Mary’s Hospital and The Hammersmith Hospital (Imperial College Hospitals) in London.
He currently runs a hypertension clinic at the Royal Devon and Exeter Hospital (RDE) and is the lead for cardiac cath labs. He is also lead for cardiac clinical research at the RDE and is an Honorary Senior Clinical Lecturer at the University of Exeter, He is principal investigator in over 20 clinical research studies in the areas of coronary artery disease, high blood pressure, atrial fibrillation, pulmonary embolus and heart failure.
Areas of interest
Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and now leads a growing research programme at the Royal Devon and Exeter Hospital in the fields of coronary artery disease and hypertension. He has published extensively and lectures internationally in the fields of coronary artery disease and hypertension.
1. Petraco R, Al-Lamee R, Gotberg M, Sharp A, et al Real-time use of instantaneous wave-free ratio: Results of the ADVISE in-practice: An international, multicenter evaluation of instantaneous wave-free ratio in clinical practice. Am Heart J.
2. Barron AJ, Hughes AD, Sharp A et al. Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy. Hypertension.
3. Ielasi A, Latib A, Godino C, Sharp AS et al. Clinical outcomes following protected carotid artery stenting in symptomatic and asymptomatic patients. J Endovasc Ther.
4. Ezzat V, Sawhney V, Sharp AS, Schilling RJ. Iatrogenic asystole in the ITU. Lancet.
5. Tapp RJ, Sharp A et al; ASCOT Investigators. Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy. JACC.
6. Bande M, Michev I, Sharp AS, Chieffo A, Colombo A. Percutaneous transcatheter aortic valve implantation: past accomplishments, present achievements and applications, future perspectives. Cardiology in Review.
7. Sharp AS et al. First trans-axillary implantation of Edwards Sapien valve to treat an incompetent aortic bioprosthesis. Catheter Cardiovascular Interventions.
8. Sharp AS et al on behalf of the ASCOT Investigators. Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. European Heart Journal.
9. Sharp AS et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc Interventions.
10. Sharp AS et al. Long-term follow-up on a large cohort of "full-metal jacket" percutaneous coronary intervention procedures. Circulation: Cardiovasc Interventions.
11. Godino C, Sharp AS, Carlino M, Colombo A. Crossing CTOs-the tips, tricks, and specialist kit that can mean the difference between success and failure. Catheter Cardiovasc Interventions.
12. Sharp AS, Colombo A. An innocent bystander in the coronary tree. European Heart Journal.
13. Colombo A, Sharp AS. The bioabsorbable stent as a virtual prosthesis. Lancet.
14. Sharp A et al. Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy. JACC.
Courses offered to GPs
Exeter Heart run educational days in cardiology for GPs and primary care nurses.
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.http://www.bcis.org.uk/pages/page_box_contents.asp?pageid=805&navcatid=88
Dr Sharp's standardised, nationally reported procedural outcomes data show a major adverse cardiac and cerebrovascular complication rate of 1% (below the expected rate of 3.4%).
Details of the breakdown of procedures performed can be found here: http://www.bcis.org.uk/pages/page_box_contents.asp?pageid=805&navcatid=88
- Fellow Royal College of Physicians 2015
- MD University of Edinburgh 2012
- MBChB University of Edinburgh 1998
Post treatment communication
Following treatment of a Bupa member, we will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Information for healthcare professionals (Bupa patients only, last 12 months)
Adult cardiac catheterisation - radial access (including coronary arteriography/catheterisation of right/left side of heart/contrast radiology) - (1-5)
Internal cardioversion - (1-5)
Adult cardiac catheterisation - radial access (including coronary arteriography/catheterisation of right/left side of heart/ contrast radiology) - with pressure wire (including fractional flow reserve measurement) - (1-5)
Rotablation of coronary vessel(s) percutaneous transluminal rotational atherectomy (PCRS) +/- insertion of stent - (1-5)